Summary
The fluorescent probe Quin-2 showed the cytosolic free-calcium concentration in platelets to be elevated in 12 hypertensive hemodialysis patients, who were compared with 12 normotensive hemodialysis patients. There was a close correlation between the free-calcium level of platelets and mean arterial pressure (r=0.88). Short-term antihypertensive treatment resulted in a reduction of free-calcium concentration and a concomitant fall in blood pressure. These results suggest an integrative contributory role for calcium in the pathophysiology of hypertension accompanying endstage renal disease.
Similar content being viewed by others
References
Bisordi JE, Holt S (1989) Digitalis like immunoreactive substances and extracellular fluid volume status in chronic hemodialysis patients. Am J Kidney Dis 13:396–403
Blaustein MP (1977) Sodium ions, calcium ions, blood pressure regulation and hypertension. A reassessment and a hypothesis. Am J Physiol 231: C165-C173
Blind E, Schmidt-Gayk H, Scharia S, Flentje D, Fischer S, Göhring U, Hitzler W (1988) Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a mid-region assay. J Clin Endocrinol Metabol 67:353–360
Bühler FR, Resink TJ (1988) Platelet membrane and calcium control abnormalities in essential hypertension. A J H 1:42–46
Da Prada M, Zürcher G (1976) Simultaneous radioenzymatic determinations of plasma and tissue adrenaline, nor-adrenaline, and dopamine within fentomole range. Life Sci 19:1161–1174
Davies DL, Schalekamp MA, Beevers DG, Brown JJ, Briggs JD, Lever AF, Morton JJ, Robertson JIS, Tree M (1973) Abnormal relation between exchangeable sodium and the renin angiotensin system in malignant hypertension and in chronic renal failure. Lancet i: 683–687
Del Greco E, Simon NM, Roguska J, Walker C (1969) Hemodynamic studies in chronic uremia. Circulation 40:87–95
Erne P, Bolli P, Burrgisser E, Bühler FR (1984) Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med 310:1084–1088
Haber E, Koerner T, Page KB, Kliman B, Purnode A (1969) Application of radioimmunoassay for the angiotensin I to the physiologic measurements of plasma renin activity in normal subjects. J Clin Endocrinol 29:1349–1355
Haller H, Philipp TH (1989) Changes in intracellular free calcium in platelets upon antihypertensive treatment. In: Meyer P, Marche P (eds) Blood cells and arteries in hypertension and atherosclerosis. Raven Press, New York, pp 189–204
Izzo JL, Izzo MS, Sterns RH, Freeman RB (1982) Sympathetic nervous system hyperactivity in hemodialysis patients. Trans Am Soc Artif Intern Organs 28:604–607
Kramer HJ, Heppe M, Penning J, Knipowski J, Klingmüller D, Düsing R, Krück F (1985) Relation of endogenous digoxin-like immunoreactive activities to salt balance and renal function in man. Klin Wochenschr 63 [Suppl 3]: 107–110
Krzesinski JM, Rorive G (1988) Influence of sodium balance on uremic blood cell ion transport. Nephron 49:126–131
Kusano E, Asano Y, Takeda K, Terao N, Hosoda S (1984) Acute and chronic hypotensive effects of nifedipine and nildipine in hypertensive patients with chronic renal failure. Drug Res 34:624–629
Lindner A, Kenny M, Meacham AJ (1987) Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets. N Engl J Med 316:509–513
Neff MS, Kim KE, Persoff M, Onesti G, Schwartz C (1971) Hemodynamics of uremic anemia. Circulation 43:876–883
Resink TJ, Tkachuk VA, Erne P, Bühler FR (1986) Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Altered activity in essential hypertension. Hypertension 8:159–166
Rink TJ, Smith SW, Tsien RW (1982) Cytoplasmic free Ca2+ in human platelets: Ca2+-thresholds and Ca-independent activation for shape-change and secretion. FEBS Lett 148:21–26
Schiffl H (1987) Modifications in cardiovascular norepinephrine responsiveness by diuretic treatment in mild renal parenchymal disease. In: Andreucci VE, Dal Canton A (eds) Diuretics: basic, pharmacological and clinical aspects. Martinus Nijhoff, Boston, pp 280–282
Schiffl H (1989) Platelet cytosolic free calcium concentration in hypertension associated with early stage kidney disease. Klin Wochenschr 67:676–681
Schohn D, Weidmann P, Jahn H, Beretta-Piccoli C (1985) Norepinephrine-related mechanisms in hypertension accompanying renal failure. Kidney Int 28:814–822
Tsien RY, Pozzan T, Rink TJ (1982) Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new intracellularly trapped fluorescent indicator. J Cell Biol 94:325–334
Vanhoutte PM (1985) Calcium-entry blockers, vascular smooth muscle and systemic hypertension. Am J Cardiol 55:17B-23B
Veall NR, Vetter H (1985) Radioisotope techniques in clinical research and diagnosis. Butterworths, London
Weidmann P, Massry SG, Coburn JW, Maxwell MH, Atle-son J, Kleeman CR (1972) Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure. Ann Intern Med 76:741–745
Weidmann P, Maxwell MH (1975) The renin-angiotensin-aldosterone system in terminal renal failure. Kidney Int 8:S219-S234
Weidmann P, Beretta-Piccoli C, Steffen F, Blumberg A, Reubi FC (1976) Hypertension in terminal renal failure. Kidney Int 9:294–301
Welt L, Sach J, Mc Manus T (1964) An ion transport defect in erythrocytes from uremic patients. Trans Assoc Am Physicians 77:169–181
Zidek W, Spieker C, Vetter H (1986) Ca2+: Ki + ratio and total extracellular calcium in essential and renal hypertension. J Hypertens 4:507–510
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schiffl, H. Correlation of blood pressure in end-stage renal disease with platelet cytosolic free-calcium concentration. Klin Wochenschr 68, 718–722 (1990). https://doi.org/10.1007/BF01647579
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01647579